Pharmaceutical Analysis & Statistics in North America Countries, May 2013 (p57)

Talk to Amrita

+1 718 303 2019

Search inside this page

Publishers

You might be interested in: therapeutics, drug, cancer, more »

1681-1730 of about 7 700 reports

Purchase Reports From Reputable Market Research Publishers

World Drug and Medication: Male Hypogonadism – Pipeline Review, H1 2012

World Drug and Medication: Male Hypogonadism – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Male Hypogonadism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Drug and Medication
  • Countries : World, United States
World Drug and Medication: Burkitt Lymphoma – Pipeline Review, H1 2012

World Drug and Medication: Burkitt Lymphoma – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Burkitt Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Pathology
  • Countries : United States, World
Metastatic Ovarian Cancer - Pipeline Review, H1 2014

Metastatic Ovarian Cancer - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

Metastatic Ovarian Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Metastatic Ovarian Cancer - Pipeline Review, H1 2014', provides an overview of the Metastatic Ovarian Cancer's therapeutic ...

  • Industries : Pathology
  • Countries : World, United States
Biological Therapy in United States: T-Cell Lymphomas – Pipeline Review, H1 2012

Biological Therapy in United States: T-Cell Lymphomas – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for T-Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Pathology
  • Countries : United States
Pathology in Japan: Peptic Ulcers – Pipeline Review, H1 2012

Pathology in Japan: Peptic Ulcers – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Peptic Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Pathology
  • Countries : World, United States, Japan
Ebola Viral Infections - Pipeline Review, H1 2014

Ebola Viral Infections - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

Ebola Viral Infections - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Ebola Viral Infections - Pipeline Review, H1 2014', provides an overview of the Ebola Viral Infections's therapeutic ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Secondary Hyperparathyroidism - Pipeline Review, H1 2014

Secondary Hyperparathyroidism - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

Secondary Hyperparathyroidism - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Secondary Hyperparathyroidism - Pipeline Review, H1 2014', provides an overview of the Secondary Hyperparathyroidism's ...

  • Industries : Pathology
  • Countries : World, Canada
World Drug and Medication: Partial Seizure – Pipeline Review, H1 2012

World Drug and Medication: Partial Seizure – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Partial Seizure, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Drug and Medication
  • Countries : United States, World
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2014

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2014', provides an overview ...

  • Industries : Pathology
  • Countries : United States
Meningococcal Meningitis - Pipeline Review, H1 2014

Meningococcal Meningitis - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

Meningococcal Meningitis - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Meningococcal Meningitis - Pipeline Review, H1 2014', provides an overview of the Meningococcal Meningitis's therapeutic ...

  • Industries : Pathology
  • Countries : World, Canada, United States
Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2014

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2014', provides an overview of the Post-Traumatic ...

  • Industries : Pathology
  • Countries : World, United States
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2014

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2014', provides an overview of the ...

  • Industries : Pathology
  • Countries : United States
Therapy in United States: Dystonia – Pipeline Review, H1 2012

Therapy in United States: Dystonia – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Dystonia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Pathology Industry: Sickle Cell Disease – Pipeline Review, H1 2012

Pathology Industry: Sickle Cell Disease – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Sickle Cell Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Pathology
  • Countries : United States, World
World Pathology: Hyperlipidemia – Pipeline Review, H1 2012

World Pathology: Hyperlipidemia – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Hyperlipidemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Pathology
  • Countries : United States, World
World Therapy: Rabies – Pipeline Review, H1 2012

World Therapy: Rabies – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Rabies, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...

  • Industries : Pathology
  • Countries : Philippines, World, India, United States
Therapy in United States: Post Menopausal Osteoporosis – Pipeline Review, H1 2012

Therapy in United States: Post Menopausal Osteoporosis – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Post Menopausal Osteoporosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

  • Industries : Pathology
  • Countries : World, Finland, United States
Reata Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Reata Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Reata Pharmaceuticals, Inc. (RPI) is a pharmaceutical company. The company develops drugs for renal, respiratory and neurodegenerative diseases. It develops antioxidant inflammation modulators ...

  • Industries : Pharmaceutical
  • Countries : United States
Sirnaomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sirnaomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Sirnaomics, Inc. is a biopharmaceutical company. The company discovers and develops targeted therapeutics for critical human diseases by using RNA interference technology. Its products include ...

  • Industries : Pathology
  • Countries : United States
TRACON Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

TRACON Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary TRACON Pharmaceuticals, Inc. (TRACON) is a biopharmaceutical company. The company licenses, develops, and commercializes therapeutics for treating cancer and age-related macular degeneration. The ...

  • Industries : Pharmaceutical
  • Countries : United States
Ranbaxy Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ranbaxy Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Ranbaxy Pharmaceuticals Inc. (RPI) is a pharmaceutical and healthcare company. The company produces, distributes and sells generic products, branded prescription products, over-the-counter drugs ...

  • Industries : Pharmaceutical
  • Countries : United States
ZS Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ZS Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary ZS Pharma, Inc. (ZS Pharma) is a specialty pharmaceutical company. It focuses on the development and marketing of its proprietary oral sorbent technology. The company is currently developing ZrSi ...

  • Industries : Pharmaceutical
  • Countries : United States
NeuroTherapeutics Pharma Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NeuroTherapeutics Pharma Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary NeuroTherapeutics Pharma Inc. (NTP) is a bio-pharmaceutical company that develops therapies for diseases associated with central nervous system (CNS). Its products focuses mainly in the therapeutic ...

  • Industries : Pharmaceutical
  • Countries : United States
PsychoGenics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PsychoGenics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary PsychoGenics, Inc. (PsychoGenics) is a preclinical contract research and drug discovery company. The company offers customized preclinical services. It provides partnered discovery capabilities ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Numerate, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Numerate, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Numerate, Inc. (Numerate) is a biotechnology company. The company combines computer science and medicinal chemistry to deliver novel drug candidates. It conducts research and development on drug ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Traversa Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Traversa Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Traversa Therapeutics, Inc. (Traversa) is a biopharmaceutical company, based in the US. It discovers, develops and commercializes RNAi delivery technologies. The company focuses on the therapeutic ...

  • Industries : Therapy
  • Countries : United States
NovaDigm Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NovaDigm Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary NovaDigm Therapeutics, Inc. (NovaDigm) is a biotechnology company. The company develops vaccines for the prevention and treatment of infectious diseases. Its products include superbugs, novadigm's ...

  • Industries : Therapy
  • Countries : United States
Teikoku Pharma USA, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Teikoku Pharma USA, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Teikoku Pharma USA, Inc. (Teikoku) is a pharmaceutical company. The company conducts research, development and manufacture of pharmaceutical transdermal products. Its products include Lidoderm, ...

  • Industries : Drug Delivery Technology
  • Countries : United States
Tocagen Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tocagen Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Tocagen Inc. (Tocagen) is a biopharmaceutical company. The company discovers, develops and commercializes products for the treatment of cancer. Its product includes Toca 511, Toca Gamma and Toca ...

  • Industries : Pharmaceutical
  • Countries : United States
PhaseBio Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PhaseBio Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary PhaseBio Pharmaceuticals, Inc. (PhaseBio) is a pharmaceutical company. The company develops drugs for the treatment of endocrine, metabolic and cardiovascular disease. It uses recombinant biopolymers, ...

  • Industries : Pharmaceutical
  • Countries : United States, North America, World

About 200 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Select Products Inc.

United States

Novartis Inc.

Switzerland

Eli Lilly and Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.